MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze MDLN →
    • FindStock Picks / Stock Screener
    • Value · MDLNIntrinsic Value Calculator
    • Invest · MDLNInvestment Case
    • Hold · MDLN5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
MDLN

MDLN

Medline Inc.

$37.04
-0.8
 (-2.11%)
Exchange:  NASDAQ
Market Cap:  32.545B
Shares Outstanding:  812M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – Instruments & SuppliesView industry performance
   
CEO:  James Boyle
Full Time Employees:  45000
Address: 
3 Lakes Drive
Northfield
IL
60093
US
Website:  https://www.medline.com
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company’s operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon’s gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized “put-away-ready” packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
MDMDLN logoMDLNMedline Inc.32.5B58.923.93.7%
RMRMD logoRMDResMed Inc.33.1B21.821.221.2%
WSWST logoWSTWest Pharmaceutical Services, Inc.27.2B46.441.117.9%
SOSOLV logoSOLVSolventum Corporation14.4B10011.716.6%
BABAX logoBAXBaxter International Inc.13.1B—12.0-1.3%
COCOO logoCOOThe Cooper Companies, Inc.11.2B21.413.04.8%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/11/04 — 3 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue23,231,00025,507,00028,432,000
Gross Profit5,223,0006,291,0007,518,000
EBITDA2,353,0003,252,0002,259,000
Operating Income1,250,0002,146,0002,212,000
Net Income234,0001,200,0001,159,000

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets36,122,00035,978,00038,484,000
Total Liabilities19,145,00019,454,00019,198,000
Total Stockholders Equity16,977,00016,524,00010,737,000
Total Debt16,828,00016,899,00012,561,000
Cash and Cash Equivalents1,585,000250,0001,939,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow1,685,0001,769,0001,744,000
Capital Expenditure-275,000-364,000-447,000
Free Cash Flow1,410,0001,405,0001,297,000
Net Income234,0001,200,0001,159,000
Net Change in Cash1,186,000-1,335,0001,692,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)42,129,451.442Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)42,912,695.388Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)42,523,666.667Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)4,441,426.127Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)4,504,489.062Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)4,473,168.038Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)1,806,984.202Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)1,850,783.482Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)1,829,030.002Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)6,847,157.550Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)6,974,455.545Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)6,911,228.020Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)2.250Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)2.280Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)2.230Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)10Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)5Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
1.13
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
58.91
?Enterprise Value
 (TTM)
: 
44.94B  ?EV/FCF
 (TTM)
: 
18.92
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
17.02%
?ROE
 (TTM)
: 
4.97%  ?ROIC
 (TTM)
: 
3.68%
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
1.07
?P/B
 (TTM)
: 
2.93  ?Current Ratio
 (TTM)
: 
4.04

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
23.90Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates MDLN intrinsic value between $27.77 – $47.04 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate MDLN Intrinsic Value

Common questions about MDLN valuation

Is Medline Inc. (MDLN) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Medline Inc. (MDLN) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is MDLN a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether MDLN trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is MDLN’s P/E ratio?

You can see MDLN’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for MDLN?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is MDLN a good long-term investment?

Whether MDLN fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Medline Inc.

  • Medline Inc. intrinsic value calculatorEstimate what the business is worth
  • Medline Inc. 5-year outlookWhat has to go right, and what could go wrong
MDLN

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-2.11
MarketSnap

Trading Metrics:

Open: 37.65   Previous Close: 37.84
Day Low: 36.94   Day High: 38.37
Year Low: 31.37   Year High: 50.88
Price Avg 50: 35.6   Price Avg 200: 39.25
Volume: 9.331M   Average Volume: 8.815M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

MDLN Investigation: Medline is being Investigated for Securities Fraud Following Product Quality Issues – Contact BFA Law if You Lost Money
18-11-2026 06:36
MDLN Investigation: Medline is being Investigated for Securities Fraud Following Product Quality Issues – Contact BFA Law if You Lost Money
Medline Inc. announces pricing of secondary offering of Class A common stock
17-11-2026 22:23
Medline Inc. announces pricing of secondary offering of Class A common stock
MDLN Securities Notice: Medline Investors that Suffered Losses when Stock Plummeted 13% are Notified to Contact BFA Law about its Securities Fraud Investigation
11-11-2026 06:03
MDLN Securities Notice: Medline Investors that Suffered Losses when Stock Plummeted 13% are Notified to Contact BFA Law about its Securities Fraud Investigation
Medline Q3 Earnings Call Highlights
04-11-2026 13:17
Medline Q3 Earnings Call Highlights
MDLN Investigation Reminder: Medline Product Quality Issues Trigger Securities Fraud Investigation for Investors – Contact BFA Law if You Lost Money
04-11-2026 06:18
MDLN Investigation Reminder: Medline Product Quality Issues Trigger Securities Fraud Investigation for Investors – Contact BFA Law if You Lost Money
MDLN Stock Market Alert: Medline Under Investigation for Potential Securities Fraud Over Product Quality Issues – Contact BFA Law if You Lost Money
30-10-2026 06:18
MDLN Stock Market Alert: Medline Under Investigation for Potential Securities Fraud Over Product Quality Issues – Contact BFA Law if You Lost Money

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Pricing

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze MDLN →
    • FindStock Picks / Stock Screener
    • Value · MDLNIntrinsic Value Calculator
    • Invest · MDLNInvestment Case
    • Hold · MDLN5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Plans
    • Settings
    • Public profile ↗
  • Log in
  • Log out

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.